Literature DB >> 2500439

Type I procollagen N-proteinase from chick embryo tendons. Purification of a new 500-kDa form of the enzyme and identification of the catalytically active polypeptides.

Y Hojima1, J A McKenzie, M van der Rest, D J Prockop.   

Abstract

Procollagen N-proteinase (EC 3.4.24.14), the enzyme that cleaves the NH2-terminal propeptides from type I procollagen, was purified over 20,000-fold with a yield of 12% from extracts of 17-day-old chick embryo tendons. The procedure involved precipitation with ammonium sulfate, adsorption on concanavalin A-Sepharose, and five additional column chromatographic steps. The purified enzyme was a neutral, Ca2+-dependent proteinase (5-10 mM) that was inhibited by metal chelators. It had a molecular mass of 500 kDa as determined by gel filtration. The enzyme contained unreduced polypeptides of 61, 120, 135, and 161 kDa that were separated by polyacrylamide gel electrophoresis in sodium dodecyl sulfate. The 135- and 161-kDa polypeptides were catalytically active after elution from the polyacrylamide gel. Other properties of 500-kDa enzyme are: 1) the Km for type I procollagen is 54 nM at pH 7.5 and 35 degrees C, and the kappa cat is 350 h-1; 2) the activation energy for reaction with type I procollagen is 7,100 cal mol-1; 3) the isoelectric point is 3.6; and 4) the enzyme specifically cleaves the NH2-terminal propeptides of type I and II procollagen, but not of type III procollagen. A minor form of N-proteinase with a 300-kDa mass was also purified and was found to contain a 90-kDa polypeptide as the major active polypeptide. The enzyme appeared to be a degraded form of the 500-kDa N-proteinase. The properties of the 300-kDa enzyme were similar to those observed for the 500-kDa enzyme.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500439

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid.

Authors:  G J Fisher; S Datta; Z Wang; X Y Li; T Quan; J H Chung; S Kang; J J Voorhees
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  Prospects and limitations of the rational engineering of fibrillar collagens.

Authors:  Ireneusz Majsterek; Erin McAdams; Eijiro Adachi; Shirish T Dhume; Andrzej Fertala
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

3.  Growing tips of type I collagen fibrils formed in vitro are near-paraboloidal in shape, implying a reciprocal relationship between accretion and diameter.

Authors:  D F Holmes; J A Chapman; D J Prockop; K E Kadler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

4.  Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen.

Authors:  L T Smith; W Wertelecki; L M Milstone; E M Petty; M R Seashore; I M Braverman; T G Jenkins; P H Byers
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

Review 5.  Fell Muir Lecture: Collagen fibril formation in vitro and in vivo.

Authors:  Karl E Kadler
Journal:  Int J Exp Pathol       Date:  2017-05-16       Impact factor: 1.925

6.  Collagen fibrils in vitro grow from pointed tips in the C- to N-terminal direction.

Authors:  K E Kadler; Y Hojima; D J Prockop
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

7.  Molecular properties and fibril ultrastructure of types II and XI collagens in cartilage of mice expressing exclusively the α1(IIA) collagen isoform.

Authors:  Audrey McAlinden; Geoffrey Traeger; Uwe Hansen; Mary Ann Weis; Soumya Ravindran; Louisa Wirthlin; David R Eyre; Russell J Fernandes
Journal:  Matrix Biol       Date:  2013-10-07       Impact factor: 11.583

Review 8.  Learning how mutations in type I collagen genes cause connective tissue disease.

Authors:  K E Kadler
Journal:  Int J Exp Pathol       Date:  1993-08       Impact factor: 1.925

9.  Synthesis of recombinant human procollagen II in a stably transfected tumour cell line (HT1080).

Authors:  A Fertala; A L Sieron; A Ganguly; S W Li; L Ala-Kokko; K R Anumula; D J Prockop
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

10.  Collagen oligomers modulate physical and biological properties of three-dimensional self-assembled matrices.

Authors:  J L Bailey; P J Critser; C Whittington; J L Kuske; M C Yoder; S L Voytik-Harbin
Journal:  Biopolymers       Date:  2010-08-24       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.